| Literature DB >> 30906328 |
Rosaria Santoro1, Gianluca Lorenzo Perrucci1, Aoife Gowran1, Giulio Pompilio1,2.
Abstract
The cellular response to the extracellular matrix (ECM) microenvironment mediated by integrin adhesion is of fundamental importance, in both developmental and pathological processes. In particular, mechanotransduction is of growing importance in groundbreaking cellular models such as induced pluripotent stem cells (iPSC), since this process may strongly influence cell fate and, thus, augment the precision of differentiation into specific cell types, e.g., cardiomyocytes. The decryption of the cellular machinery starting from ECM sensing to iPSC differentiation calls for new in vitro methods. Conveniently, engineered biomaterials activating controlled integrin-mediated responses through chemical, physical, and geometrical designs are key to resolving this issue and could foster clinical translation of optimized iPSC-based technology. This review introduces the main integrin-dependent mechanisms and signalling pathways involved in mechanotransduction. Special consideration is given to the integrin-iPSC linkage signalling chain in the cardiovascular field, focusing on biomaterial-based in vitro models to evaluate the relevance of this process in iPSC differentiation into cardiomyocytes.Entities:
Year: 2019 PMID: 30906328 PMCID: PMC6393933 DOI: 10.1155/2019/8203950
Source DB: PubMed Journal: Stem Cells Int Impact factor: 5.443
Integrin heterodimers, extracellular ligands and downstream signalling pathways.
| Integrin heterodimers | Ligands | Pathway | Ref. | |
|---|---|---|---|---|
| Collagen receptor |
| Collagen (IV, I, and IX) | (i) RhoA/ROCK | [ |
|
| Collagen (I, IV, and IX) | (i) RhoA/ROCK | [ | |
|
| Collagen (IV, VI, II, and IX) | (i) RhoA/ROCK | [ | |
|
| Collagen (I, IV, and IX) | (i) RhoA/ROCK | ||
|
| ||||
| Laminin receptor |
| Laminin (LN-511, LN-332, and LN-211) | (i) RhoA/ROCK | [ |
|
| Laminin (LN-511, LN-211, LN-411, and LN-111) | (i) RhoA/ROCK | ||
|
| Laminin (LN-511, LN-332, LN-111, and LN-411) | (i) RhoA/ROCK | ||
|
| Laminin (LN-332, LN-511) | / | ||
|
| ||||
| RGD receptor |
| Fibronectin, vitronectin (RGD) | (i) RhoA/mDia | |
|
| Vitronectin, fibronectin, and fibrinogen (RGD) | (i) RhoA/mDia | [ | |
|
| Vitronectin (RGD) | (i) RhoA/mDia | [ | |
|
| Fibronectin, TGF- | / | ||
|
| Vitronectin, TGF- | / | ||
|
| Fibronectin (RGD) | In the leading edge of moving cells in the 2D surface | [ | |
|
| Fibronectin, vitronectin, and nephronectin (RGD) | / | ||
|
| Fibrinogen, fibronectin (RGD) | / | ||
|
| ||||
| Leucocyte-specific receptor |
| Tenascin-C, VEGF-C, and VEGF-D | / | |
|
| Fibronectin, VCAM-1 (LDV) | / | ||
|
| MadCAM-1 (LDV), fibronectin, and VCAM-1 | / | ||
|
| ICAM-3, VCAM-1 | / | ||
|
| E-cadherin | / | ||
|
| ICAM-1, ICAM-2, ICAM-3, and ICAM-5 | / | ||
|
| iC3b, fibrinogen | / | ||
|
| iC3b, fibrinogen | / | ||
Figure 1Cytoplasmatic membrane and nuclear envelope mechanotransduction protein complexes. (a) The image depicts the main mediators involved in the mechanotransduction chain, starting from the integrin subunits, specifically binding ECM compounds, to cytoskeleton polymerization, through the activity of focal adhesion effectors. (b) The figure summarizes the link between cytoskeleton and nuclear lamin A/C, through the nuclear envelope complexes, responsible for the gene expression modulation downstream to mechanotransduction.
Figure 2Integrin expression in iPSC at different stages of differentiation. The picture on (a), inspired by the Waddington diagram and John Piper's original artwork [103], represents iPSC undergoing cardiomyocyte differentiation. During these early stages, cells lose their potency, acquiring, in parallel, cardiomyocyte features. This process is linked to a specific integrin expression, further exacerbated by the growing substrates. As displayed in (b), cells with a higher potency and a lower degree of differentiation express, on compliant substrates, a higher amount of integrin heterodimers, preferentially containing αν integrin subunits. On the other hand, iPSC on rigid substrates lose potency in favour of differentiation and express integrins with β1 integrin subunits.
Figure 3Engineered materials supporting in vitro modelling. Integrin-mediated pathways relevant for iPSC cardiac differentiation can be enhanced in vitro by the use of ad hoc-designed biomaterials. Toward this aim, chemical, geometrical, mechanical, and physical properties of the substrates are relevant.